54 related articles for article (PubMed ID: 6890438)
1. [Nifedipine in hypertrophic obstructive cardiomyopathy].
Schanzenbächer P; Schick KD; Kochsiek K
Dtsch Med Wochenschr; 1982 Dec; 107(48):1842-6. PubMed ID: 6890438
[TBL] [Abstract][Full Text] [Related]
2. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Senn M; Hess OM; Krayenbühl HP
Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
[TBL] [Abstract][Full Text] [Related]
3. [Effect of dynamic exercise on left ventricular hemodynamics in obstructive cardiomyopathy].
Grbic M; Sigwart U; Rivier JL; Payot M; Jaeger M
Schweiz Med Wochenschr; 1980 Nov; 110(45):1692-6. PubMed ID: 7197048
[TBL] [Abstract][Full Text] [Related]
4. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy.
Steendijk P; Meliga E; Valgimigli M; Ten Cate FJ; Serruys PW
Heart; 2008 Oct; 94(10):1318-22. PubMed ID: 18450844
[TBL] [Abstract][Full Text] [Related]
6. [Relations between ventricle function, myocardial oxygen consumption and coronary circulation following sublingual administration of nitroglycerin].
Hahn N; Jehle J; Pölitz B; Schmiel FK; Spiller P
Z Kardiol; 1983 Aug; 72(8):456-64. PubMed ID: 6414193
[TBL] [Abstract][Full Text] [Related]
7. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
Nagashima J
J Cardiol; 1991; 21(1):75-86. PubMed ID: 1817183
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
[TBL] [Abstract][Full Text] [Related]
9. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF; Braunwald E
N Engl J Med; 1980 Oct; 303(14):801-3. PubMed ID: 7191052
[No Abstract] [Full Text] [Related]
10. [Changes in diastolic ventricular properties by intravenous nifedipine infusion in patients with unstable angina pectoris].
Mauser M; Karsch KR; Wagner S; Seipel L
Z Kardiol; 1985 Oct; 74(10):590-7. PubMed ID: 4072330
[TBL] [Abstract][Full Text] [Related]
11. [Diastolic ventricular function in hypertrophic, obstructive and non-obstructive cardiomyopathy--effect of gallopamil].
Olbrich HG; Hopf R; Klepzig H; Hör G; Maul FD; Kaltenbach M
Z Kardiol; 1989; 78 Suppl 5():29-35. PubMed ID: 2631478
[TBL] [Abstract][Full Text] [Related]
12. [Nifedipine in acute myocardial infarction (author's transl)].
Oeff M; Beck OA; Halilović E; Hochrein H
Dtsch Med Wochenschr; 1980 Oct; 105(43):1497-501. PubMed ID: 7428655
[TBL] [Abstract][Full Text] [Related]
13. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
[TBL] [Abstract][Full Text] [Related]
14. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
Hopf R; Kaltenbach M
Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
[TBL] [Abstract][Full Text] [Related]
15. [Left ventricular systolic and diastolic functions in hypertrophic cardiomyopathy: with special reference to clinical symptom and the effects of calcium blocking agent (nifedipine)].
Yamakado T; Higashiyama S; Nakano T; Takezawa H
J Cardiol Suppl; 1987; 16():53-63. PubMed ID: 3509683
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
Hopf R; Thomas J; Klepzig H; Kaltenbach M
Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
Lösse B; Loogen F; Schulte HD
Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic examinations concerning the effects of cardiac glycosides in hypertrophic obstructive cardiomyopathy (HOCM)].
Assmann I; Fiehring H; Oltmanns G; Dittrich P; Basche S; Strauss HJ
Z Kardiol; 1982 Jul; 71(7):473-9. PubMed ID: 6890276
[TBL] [Abstract][Full Text] [Related]
19. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF
Circulation; 1982 Mar; 65(3):499-507. PubMed ID: 7198942
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
Fedor JM; Stack RS; Pryor DB; Phillips HR
Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
